A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma

Table 1

Clinical features of ESCA patients.

Variable	No. of patients (%)
Sex
Male	145 (86.3)
Female	23 (13.7)
Age (years)
<60	75 (44.6)
≥60	93 (55.4)
T stage
T1 + T2	68 (40.5)
T3 + T4	100 (59.5)
Lymph node status
N0	69 (41.1)
N1–3	85 (50.6)
NA	14 (8.3)
Distant metastasis
M0	137 (81.5)
M1	16 (9.5)
Mx	15 (8.9)
Histologic grade
Gx + G1	90 (53.6)
G2 + G3	78 (46.4)
Pathologic stage
I	15 (8.9)
II	76 (45.2)
III	61 (36.3)
IV	16 (9.5)

ESCA: esophageal carcinoma; NA : not available; No: number.